| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.92M | 7.66M | 30.04M | 66.09M | 55.03M | 28.21M |
| Gross Profit | -11.43M | -15.97M | -7.59M | 25.42M | 17.18M | 8.79M |
| EBITDA | -5.54M | -38.22M | -30.03M | 43.66M | 26.19M | 6.60M |
| Net Income | -27.25M | -58.94M | -61.80M | 10.06M | -924.72K | -8.42M |
Balance Sheet | ||||||
| Total Assets | 164.63M | 169.46M | 226.67M | 292.43M | 309.86M | 294.04M |
| Cash, Cash Equivalents and Short-Term Investments | 7.74M | 10.08M | 72.22M | 108.23M | 95.77M | 94.22M |
| Total Debt | 7.98M | 8.73M | 9.48M | 9.68M | 10.06M | 10.61M |
| Total Liabilities | 22.42M | 25.75M | 21.42M | 20.81M | 23.22M | 17.01M |
| Stockholders Equity | 142.21M | 143.71M | 205.25M | 271.62M | 286.64M | 277.02M |
Cash Flow | ||||||
| Free Cash Flow | -498.99K | -59.85M | -32.75M | 13.59M | -6.78M | -12.41M |
| Operating Cash Flow | -658.63K | 675.07K | -32.75M | 51.15M | 23.31M | 9.31M |
| Investing Cash Flow | -25.27K | -60.55M | 0.00 | -37.56M | -30.09M | -21.72M |
| Financing Cash Flow | -246.92K | -249.24K | -267.81K | -264.86K | -290.60K | -264.98K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $87.45M | 47.39 | 5.08% | ― | 0.18% | -54.25% | |
56 Neutral | $82.39M | -257.86 | 0.02% | 1.33% | -0.97% | -99.67% | |
49 Neutral | $11.72M | -0.62 | -77.79% | ― | 39.37% | 69.81% | |
47 Neutral | $53.33M | -4.53 | ― | ― | 11013.00% | 39.85% | |
44 Neutral | $5.87M | -0.09 | -43.37% | ― | 61.85% | 49.02% |
On December 22, 2025, Gulf Resources, Inc. completed the sale of 100% of the equity in its indirect subsidiary Shouguang Yuxin Chemical Industry Co., Limited to Shandong Rongyuan Pharmaceutical Co., Ltd. for gross consideration of RMB 21.23 million (about US$3.0 million), following approval of the industrial and commercial change registration by the relevant Chinese regulator, which recorded the buyer as the sole shareholder. In connection with the closing of this disposition, the company provided historical financial statements for the year ended December 31, 2024 and the nine months ended September 30, 2025, along with unaudited pro forma condensed consolidated financial information reflecting the impact of the sale on its balance sheet, liabilities and overall financial position as of September 30, 2025.
On December 18, 2025, Gulf Resources, Inc. said it had received a December 15, 2025 notice from the Shouguang Municipal People’s Government Office requiring the company to temporarily suspend certain operations in Shouguang City for a designated period. The company indicated that this seasonal halt is intended to support the local government’s objectives for orderly brine extraction, more efficient use and development of brine resources, and environmental protection, and noted that bromine demand typically weakens around Chinese New Year while crude salt processing becomes more difficult in winter, suggesting the suspension may have limited commercial impact during this slower operating season.
On December 10, 2025, Gulf Resources‘ subsidiary, Shouguang City Haoyuan Chemical Company Limited, entered into an equity transfer agreement to sell 100% of its equity interests in Shouguang Yuxin Chemical Industry Co., Limited to Shandong Rongyuan Pharmaceutical Co., Ltd. for RMB 21.2 million. This strategic decision follows the prolonged suspension of operations at the Yuxin Chemical facility, which negatively impacted Gulf Resources’ performance. The sale is expected to relieve the company of operational burdens associated with the facility, allowing it to concentrate resources on more profitable business segments.
On December 1, 2025, Gulf Resources, Inc. announced that it had regained compliance with the Nasdaq’s minimum bid price requirement, allowing its securities to continue being listed and traded on the Nasdaq Capital Market. This compliance achievement led to the cancellation of a scheduled hearing before the Nasdaq Hearings Panel, marking a significant operational milestone for the company.
On November 19, 2025, Gulf Resources, Inc. filed its quarterly report for the quarter ended September 30, 2025, with the SEC. This filing is a standard procedure for public companies to disclose financial performance and other relevant information to stakeholders.
On November 12, 2025, Gulf Resources, Inc. announced an update on its appeal process regarding Nasdaq’s delisting determination. Following a 1-for-10 reverse stock split effective October 27, 2025, the company’s stock maintained a closing bid price above $1.00 for over ten consecutive trading days as of November 10, 2025. Consequently, the company requested to cancel the scheduled December 9, 2025, Nasdaq hearing, pending review and confirmation by the Listing Analyst. Despite the suspension of its stock trading on November 11, 2025, Gulf Resources is preparing for the hearing and remains committed to complying with Nasdaq’s requirements to resume trading.
On November 4, 2025, Gulf Resources received a delist determination letter from Nasdaq due to non-compliance with Listing Rule 5550(a)(2). The company has taken steps to address this by implementing a one-for-ten reverse stock split on October 27, 2025, and filing an appeal on November 7, 2025, to present a compliance plan to the Nasdaq Hearings Panel. The outcome of the appeal and the company’s ability to regain compliance remain uncertain.
Gulf Resources, Inc. announced a 1-for-10 reverse stock split of its common stock, effective October 27, 2025, to regain compliance with Nasdaq’s minimum bid price requirement. This move will reduce the number of shares outstanding from approximately 13.63 million to 1.36 million, with stockholders’ positions adjusted automatically without requiring further action.